This website uses cookies to enhance the user experience.
S

SKYTEK HOLDING AS919 899 387

Research
Limited company
Kompani Linges vei 29A 4045 HAFRSFJORD, Norge

SKYTEK HOLDING AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board
Years since formation
7 years
since Nov 13, 2017
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
30,000
1 share class
Total number of shareholders
1
person
Belongs to group of

Financials

Total operating income 2023
3,206,100
NOK
Annual total result 2023
2,446,002
NOK
Total equity 2023
8,515,775
NOK
Last update: Dec 11, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO
100 %
directly

Board

NameRoleShares
Chairman
100 %
directly

Others

NameRoleShares
J
JM ØKONOMIPARTNER AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Chairman
100 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classNumber of sharesShare
Ordinary shares
30,000
100 %

Shares owned by the SKYTEK HOLDING AS

NameShare classNumber of sharesShare
S
SIDDIS EIENDOM AS
Ordinary shares
10,000
100 %
S
SIFOTEK AS
Ordinary shares
1,860,000
93 %
E
EXPERWELL AS
Ordinary shares
750,000
75 %
Last update: May 24, 2024

Group structure

  • Total operating income 2023: NOK 3,206,100
    Operating profit 2023: NOK 3,119,271
    Employees: 0

Financials

in NOK

Summary

Year202320222021
Total operating income
3,206,100
2,049,300
2,202,350
Annual Total Result
2,446,002
4,585,564
1,447,840
Total assets
12,667,169
13,219,872
8,297,638
Total liabilities
4,151,393
4,675,319
4,338,648
Total equity
8,515,775
8,544,554
3,958,989

P&L

Year202320222021
Total operating income
3,206,100
2,049,300
2,202,350
Total operating costs
86,829
335,157
259,589
Operating result
3,119,271
1,714,144
1,942,761
Financial income/costs
16,629
3,269,440
-69,000
Profit before tax
3,135,900
4,983,583
1,873,761
Total tax & extraordinary income/cost
689,898
398,019
425,921
Annual Total Result
2,446,002
4,585,564
1,447,840

Balance overview

Year202320222021
Total fixed assets
10,354,065
9,918,095
7,415,455
Total current assets
2,313,103
3,301,777
882,183
Total assets
12,667,169
13,219,872
8,297,638
Short term debt
4,141,181
1,854,787
1,348,892
Long term debt
10,212
2,820,532
2,989,756
Total liabilities
4,151,393
4,675,319
4,338,648
Contributed capital
30,000
2,505,000
2,505,000
Retained earnings
8,485,775
6,039,554
1,453,989
Total equity
8,515,775
8,544,554
3,958,989
Total equity and liabilities
12,667,169
13,219,872
8,297,638

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology